角膜移植市場規模、佔有率及成長分析（按類型、適應症、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，角膜移植市場規模將達到 5.2674 億美元，到 2025 年將達到 5.6624 億美元，到 2033 年將達到 10.0988 億美元，在預測期（2026-2033 年）內，複合年成長率為 7.5%。

市場分析顯示，角膜移植在圓錐角膜的治療中發揮至關重要的作用，約有10-15%的患者最終需要接受此項手術。這凸顯了角膜移植在控制這種影響全球眾多患者的疾病中的重要角色。此外，角膜盲已被公認為重要的公共衛生問題，是繼青光眼和白內障之後失明的第三大原因。全球約有1000萬人受到影響，凸顯了尋找有效角膜健康解決方案的迫切性。人們對這一問題的日益關注可能會推動對角膜移植手術的需求，使其成為眼科市場的重要組成部分，並強調持續改進治療方案的必要性。

角膜移植市場促進因素

全球角膜移植市場的主要促進因素之一是導致視力障礙和角膜盲的眼科疾病和病症的增加。人口老化、糖尿病盛行率上升以及環境因素等因素導致需要角膜移植的患者數量不斷增加，從而提高了對有效手術治療方法的需求。此外，手術技術的進步和術後護理的改善提高了移植成功率，進一步激勵了患者和醫療機構選擇角膜移植手術。這種日益增強的認知和不斷改善的治療效果是推動市場成長的關鍵因素。

限制角膜移植市場的因素

全球角膜移植市場面臨的主要限制因素之一是供體角膜短缺。合適的捐贈者組織數量有限，會限制移植手術的成功率，影響患者預後和整體市場成長。此外，與器官捐贈相關的嚴格法規和倫理考量也會使取得過程變得複雜。這種短缺會導致患者等待時間延長，造成患者沮喪，並可能加重視力障礙。此外，角膜移植手術和術後護理的高昂費用也會使患者和醫療機構對這項救命手術望而卻步，進一步限制市場擴張。

角膜移植市場趨勢

角膜移植市場正經歷顯著成長，這主要得益於多種因素的共同作用，推動了對創新醫療解決方案的需求。角膜移植技術的進步顯著改善了多種眼科疾病的治療效果，使其成為患者和醫療機構的首選治療方案。此外，人口老化加劇，罹患福克斯角膜營養不良等眼科疾病的風險也隨之增加，進一步推動了市場擴張。這種人口結構的變化不僅增加了對角膜移植的需求，也刺激了研發投入，從而改善了眼科領域的治療效果，並提高了醫療服務的可及性。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析

全球角膜移植市場規模（按類型及複合年成長率分類）（2026-2033 年）

• 穿孔性角膜移植術
• 內皮移植
• Descemet 細胞自動內皮移植 (DSAEK)
• 角膜移植
• 角膜緣幹細胞移植
• 其他

全球角膜移植市場規模（按適應症和複合年成長率分類）（2026-2033 年）

• 真菌性角膜潰瘍
• 水痘角膜疾病
• 圓錐角膜
• 角膜炎
• 角膜基質營養不良
• 其他

全球角膜移植市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 眼科診所
• 其他

全球角膜移植市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• CorneaGen（USA）
• Eversight（USA）
• Lions VisionGift（USA）
• Keramed Inc.（USA）
• EyeYon Medical（Israel）
• Aurolab（India）
• Presbia PLC（Ireland）
• Mediphacos（Brazil）
• DIOPTEX GmbH（Austria）
• AJL Ophthalmic SA（Spain）
• Florida Lions Eye Bank（USA）
• Ocular Systems Inc.（USA）
• Gebauer Medizintechnik GmbH（Germany）
• Tomey Corporation（Japan）
• SightLife（USA）
• Ampleye（Netherlands）
• Allotex（USA）
• Eye Bank Association of America（EBAA）（USA）
• Boston Keratoprosthesis（Boston KPro）（USA）
• IOPtima Ltd.（Israel）

結論與建議

Corneal Transplant Market size was valued at USD 526.74 Million in 2024 and is poised to grow from USD 566.24 Million in 2025 to USD 1009.88 Million by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

Market insights reveal that corneal transplants play a crucial role in treating keratoconus, with 10-15% of patients eventually requiring this surgical intervention. This highlights the essential nature of corneal implants in managing the condition, which affects a significant number of individuals globally. Furthermore, corneal blindness is recognized as a major public health issue, being the third leading cause of blindness after glaucoma and cataracts. Approximately 10 million people are affected worldwide, emphasizing the urgent need for effective solutions in corneal health. The increasing awareness of these issues is likely to drive demand for corneal transplant procedures, positioning them as a vital component in the ophthalmology market and underscoring the need for continued advancements in treatment options.

Top-down and bottom-up approaches were used to estimate and validate the size of the Corneal Transplant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Corneal Transplant Market Segments Analysis

Global Corneal Transplant Market is segmented by Type, Indications, End-User and region. Based on Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Corneal Graft, Corneal Limbal Stem Cell Transplant and Others. Based on Indications, the market is segmented into Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, Corneal Stromal Dystrophies and Others. Based on End-User, the market is segmented into Hospital, Eye Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Corneal Transplant Market

One of the key market drivers for the global corneal transplant market is the increasing prevalence of ocular diseases and conditions that lead to vision impairment and corneal blindness. As factors such as the aging population, rising incidence of diabetes, and environmental influences contribute to a growing number of patients requiring corneal transplants, there is an enhanced demand for effective surgical solutions. Additionally, advancements in surgical techniques and post-operative care have improved transplant success rates, further encouraging patients and healthcare providers to pursue corneal transplant procedures. This heightened awareness and improved outcomes are vital in driving market growth.

Restraints in the Corneal Transplant Market

One significant market restraint for the global corneal transplant market is the shortage of donor corneas. The limited availability of suitable donor tissues can hinder the volume of successful transplant surgeries, impacting patient outcomes and overall market growth. Furthermore, stringent regulations and ethical considerations surrounding organ donation can complicate the procurement process. This scarcity leads to prolonged waiting periods for patients, contributing to dissatisfaction and potentially worsening visual impairment. Additionally, the high costs associated with corneal transplantation procedures and follow-up care may deter patients and healthcare providers from pursuing these lifesaving interventions, further constraining market expansion.

Market Trends of the Corneal Transplant Market

The corneal transplant market is experiencing remarkable growth driven by a confluence of factors that enhance the demand for innovative medical solutions. Technological advancements in corneal implants have significantly improved their effectiveness in treating a variety of eye disorders, making them a preferred choice for both patients and healthcare providers. Additionally, the rising geriatric population, with increasing susceptibility to eye conditions such as Fuchs' dystrophy, further fuels market expansion. This demographic shift not only heightens the need for corneal transplants but also fosters investments in research and development, leading to better treatment outcomes and greater accessibility in ophthalmology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global Corneal Transplant Market Size by Type & CAGR (2026-2033)

• Market Overview
• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
• Corneal Graft
• Corneal Limbal Stem Cell Transplant
• Others

Global Corneal Transplant Market Size by Indications & CAGR (2026-2033)

• Market Overview
• Fungal Corneal Ulcer
• Bullous Keratopathy
• Keratoconus
• Keratitis
• Corneal Stromal Dystrophies
• Others

Global Corneal Transplant Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospital
• Eye Clinics
• Others

Global Corneal Transplant Market Size & CAGR (2026-2033)

• North America (Type, Indications, End-User)
  • US
  • Canada
• Europe (Type, Indications, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indications, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indications, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indications, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CorneaGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eversight (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lions VisionGift (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Keramed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EyeYon Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurolab (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Presbia PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediphacos (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIOPTEX GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AJL Ophthalmic S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Florida Lions Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocular Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gebauer Medizintechnik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tomey Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SightLife (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ampleye (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allotex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eye Bank Association of America (EBAA) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Keratoprosthesis (Boston KPro) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IOPtima Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations